Cardiol Therapeutics Inc
NASDAQ:CRDL

Watchlist Manager
Cardiol Therapeutics Inc Logo
Cardiol Therapeutics Inc
NASDAQ:CRDL
Watchlist
Price: 1.12 USD 1.82% Market Closed
Market Cap: 77.7m USD

Intrinsic Value

CRDL's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one CRDL stock under the Base Case scenario is 0.55 USD. Compared to the current market price of 1.12 USD, Cardiol Therapeutics Inc is Overvalued by 51%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CRDL Intrinsic Value
0.55 USD
Overvaluation 51%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Cardiol Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
CRDL
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CRDL cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

No research report yet

Want a deep‑dive on Cardiol Therapeutics Inc?
Request it below and we’ll move it up the queue.

Request This Report
What’s Inside the Report:
Whether it’s a smart buy right now
If the stock is undervalued
Its long-term growth potential
Whether the dividend is safe
How it compares to peers
How strong its moat is
Whether management can be trusted
You Can Read These Reports Right Now
Dive in while we’re working on Cardiol Therapeutics Inc’s research
View All Researches
Cardiol Therapeutics Inc
NASDAQ:CRDL
CA
Pharmaceuticals
Market Cap
78.6m USD
IPO
Dec 20, 2018
CA
Pharmaceuticals
Market Cap
78.6m USD
IPO
Dec 20, 2018
Price
$false
EPS
CA$false
AI Assistant
AI Assistant
Ask me anything about Cardiol Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cardiol Therapeutics Inc

Current Assets 17.3m
Cash & Short-Term Investments 15.9m
Receivables 266.7k
Other Current Assets 1.1m
Non-Current Assets 238k
PP&E 237.9k
Other Non-Current Assets 100
Efficiency

Free Cash Flow Analysis
Cardiol Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cardiol Therapeutics Inc

Revenue
0 CAD
Operating Expenses
-38.3m CAD
Operating Income
-38.3m CAD
Other Expenses
2.2m CAD
Net Income
-36.1m CAD
Fundamental Scores

CRDL Profitability Score
Profitability Due Diligence

Cardiol Therapeutics Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

35/100
Profitability
Score

Cardiol Therapeutics Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

CRDL Solvency Score
Solvency Due Diligence

Cardiol Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
60/100
Solvency
Score

Cardiol Therapeutics Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CRDL Price Targets Summary
Cardiol Therapeutics Inc

Wall Street analysts forecast CRDL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRDL is 6.89 USD with a low forecast of 5.94 USD and a high forecast of 8 USD.

Lowest
Price Target
5.94 USD
431% Upside
Average
Price Target
6.89 USD
515% Upside
Highest
Price Target
8 USD
614% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cardiol Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CRDL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one CRDL stock?

The intrinsic value of one CRDL stock under the Base Case scenario is 0.55 USD.

Is CRDL stock undervalued or overvalued?

Compared to the current market price of 1.12 USD, Cardiol Therapeutics Inc is Overvalued by 51%.

Back to Top